Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116000) titled 'Development and Clinical Translational Application of Anti-Tuberculosis Drug TDM Detection System Based on Dry Blood Spot-HPLC-MS/MS Technology' on Jan. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Hangzhou Red Cross Hospital
Condition:
Tuberculosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-05
Target Sample Size: DBS Detection Technology Verification Group:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303695
Published by HT Digital Content Services with permission from He...